chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; whole body aches; fever; tiredness; This is a spontaneous report from a contactable nurse. A 20-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), via an unspecified route of administration on an unknown date in Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient not been tested for COVID-19. The patient experienced flu like symptoms, whole body aches, fever, tiredness on an unknown date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt states she broke out in hives 1 week after vaccine, lasted 1 day, then resolved. At the time her 2nd vaccine was due, she had sore throat, ear ache, URI, vomiting, severe HA, body aches. Tested for covid 3 times- All negative. Completed steroid and z pack. On 5/24/2021, went to ER and was diagnosed with Bells Palsy, placed on steroid and antiviral.
Information has been received from a nurse practitioner concerning a 15 month old male who on 05-MAY-2009 was inadvertently vaccinated with a dose of ZOSTAVAX (Merck) due to a human error. No adverse effect reported. Follow up information received on 08-MAY-2009 from the nurse practitioner stated that the nurse who administered the dose of ZOSTAVAX (Merck) (lot # 662857/1560X) was a "float nurse" who does not routinely work at the office. The reporter indicated that the ZOSTAVAX (Merck) was stored on the same shelf as VARIVAX (Merck). According with the reporter the nurse forgot to double check so it was human error. It was also reported that "the vial was labeled correctly as ZOSTAVAX". The nurse practitioner spoke with the patient's mother and the patient was "doing well". Additional information is not expected.
Lab test first on 6/20/2021. No Sample available for further testing from this date. 6/25/2021 -  Chest pain, Xray (-). Received albuterol treatments and discharged. Told she did not qualify for Regeneron 6/30/2021 - Visit to healthcare facility 07/01/2021  Admitted Interview on 7/2/2021 case stated she was going to receive Remdesivir   Sx onset  06/18/2021  Sore throat. Achy, sever headache; worse by 6/20/2021 6/22/2021  abdominal cramping, vomiting, diarrhea 6/23/2021  anosmia 6/25/2021  chest pain On 7/2/21, case was admitted, on O2 (no vent), not in ICU. Chest Xray negative for pleural effusion, blood clots. 7/6/21 case was transferred to ICU.
Severe headache statrted about 3hrs after the injection. Headache continuted for about 24hrs. I took 2 Tylenol at roughly 4:30am following the vaccine and that helped somewhat but pain returned roughly 4hrs later.  Light chills were had for about 36hrs. Extreme tiredness was intermittent for about 30hrs.
Vaccine was given at 10:00 am. Around 5:00 pm started to feel very tired, nauseated and weak. Went to bed and around 9:00 pm woke up and felt chilled to the core and violently shivering, the front of my face and the bottom of my feet and hand where numb. My eyes had a hard time focusing. Was able to call my sister for help. She called the Emergency room and asked for help on what to do. With the symptoms and history of reactions to other vaccines having left sided weakness and unable to sit up she was instructed to call 911 for transport to the emergency room. I had severe cramping in muscles and joints and a bad headache and had a low grade fever.
After receiving the COVID Booster I developed a rash and bruising distal to the injection site on my left arm. I also started to experiencing chills ,low grade fever, headaches and cough over the next four days.  Treated with over the counter medication.
No adverse event. Hib was given to 16 y.o. (outside of age recommendation) in error.
Shots given at 13:30 on 05/12/2003.  At 17:00 infant started with inconsolable high pitched scream which alternated with incompatability for first 24-48 hrs after shots.  No vomiting, no fever, ate well, but spit up more than usual.
At 3:00 AM on 1/18/21 she was awoken from sleep with shoulder pain, hip girdle pain, long bones of the thighs, could not raise arms above head, neuropathy of the palms, pain in wrist, tingling, numbness, stiffness of wrists, stiff fingers, hurt to bend fingers with pulsing capillaries.  Started more centrally then extended down to extremities, did have some pain in ankles, neuropathy to the feet.  Much worsening of the mucosal dryness of her eyes, mouth, lips, throat to the point that she was hoarse, and also her vaginal mucosa started to dry up as well.   She took Acetaminophen, etc.  She then was given some narcotics, which did not help the pain symptoms either.  Her doctor had no answers, and did not prescribe her anything.   Her eyes and throat dryness has waned somewhat.  She is still having pain in her shoulder girdle.  Does have the neuropathy pain, still hard to bend fingers.  She had a very severe reaction this past weekend where she could not eat from Saturday to Wednesday due to nausea.  She did get an order for Zofran on Monday, 2/15/21.  She is still taking the Acetaminophen and Naprosyn, not taking the Norco due to constipation.   Started taking her Synthroid again, but low dose.  She is an RN and not able to work due to this condition.   She also become leukopenic, her  WBC's were lower than normal at 2.9, and her neutrophils dropped to a suboptimal level as well.  She is now immunocompromised, and another reason for her not going to work as she works in an overflow unit for COVID patient's.
On evening of 11/17/2012 noticed increasing itching and a red area of approx 60mm.  Took Benadryl po at that time.  Itching and redness lasted until approximatly 11/21/2012.  Did not see a physician.
pt recv vax; devel breakthrough chicken pox p/ being exposed to wild type on 21jan96;devel only a few pox;
The vial was initially stored in the refrigerator on 01-Sep-2022 and vaccine was  administered on 13-Oct-2022.; No adverse event; Dose administered after 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Sep-2022 and vaccine was  administered on 13-Oct-2022.) and NO ADVERSE EVENT (No adverse event) in a 42-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C3) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Oct-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Sep-2022 and vaccine was  administered on 13-Oct-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Sep-2022 and vaccine was  administered on 13-Oct-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Sep-2022 and vaccine was  administered on 13-Oct-2022.).    No concomitant medications were reported.     It was unknown if patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The vial was initially stored in the refrigerator on 01-Sep-2022. BUD was reported as 01-Oct-2022. The vial did not underwent any temperature excursions.  No treatment medications were reported.
He had first shot at their Covid immunization clinic. No reaction after first shot on 02/02/2021. No  reaction after second shot 2/26/2021 until Tuesday March 2 when he lost his taste and smell, he had no temp and no other symptoms. He was tested on 3/3/2021 and it was negative. So only problem was the loss of taste and smell.
This spontaneous report was received from a licensed practical nurse refers to an unknown number of patients that might have been vaccinated with a doses of PNEUMOVAX 23 (doses, routes and lot numbers not reported) that were improperly stored. It was noted that the nurse was not sure how many patients would be involved and dates of administration were not available at the time of the report. No adverse events were reported. Attempts are being made to obtain additional information identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports from the same source. Additional information has been requested.
Same day of receiving vaccine: forehead becoming stiff and right eyebrow raised around 7 PM; by 10 PM both eyes were with red ithing rash along with rhinitis. 8/6/21 - awoke with swollen eyes and face rash and neck "discoid" that had resolved earlier inweek had returned. Throat tight but no difficulty breathing at time.
Right shoulder pain, can not use RUE very well at all. Arm pain began within about an hour of the vaccine.
Patient received VARIVAX 5/21/09 patient had rash 6/17/09 was seen in office 6/18/09.
exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 36-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 25-Jul-2020 and the estimated date of delivery was 01-Apr-2021. On 18-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 18-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Aug-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Previous pregnancy end date included 24-Jan-2018 with live birth. On an unknown date ultrasound , glucose test were done showed normal findings. No treatment information provided.
eczema (arms, stomach); rash redness; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (eczema (arms, stomach)) and RASH (rash redness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Atopic dermatitis (For 6 years) and Cancer. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLERGIA [FEXOFENADINE HYDROCHLORIDE]), MONTELUKAST SODIUM (SINGULAIR) and HYDROXYZINE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced ECZEMA (eczema (arms, stomach)) and RASH (rash redness). At the time of the report, ECZEMA (eczema (arms, stomach)) and RASH (rash redness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Non-significant follow-up added to include AE contact info
3 days after vaccination swollen right side of tongue, patient took allergy meds and it went away.
Fever; chills; headache; neck pain; pain at injection site; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Apr-2021 and was forwarded to Moderna on 23-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (chills), HEADACHE (headache), NECK PAIN (neck pain) and VACCINATION SITE PAIN (pain at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Breast cancer. Concomitant products included ANASTROZOLE for Breast cancer.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced PYREXIA (Fever), CHILLS (chills), HEADACHE (headache), NECK PAIN (neck pain), VACCINATION SITE PAIN (pain at injection site) and NAUSEA (nausea). At the time of the report, PYREXIA (Fever), CHILLS (chills), HEADACHE (headache), NECK PAIN (neck pain), VACCINATION SITE PAIN (pain at injection site) and NAUSEA (nausea) outcome was unknown. Not Provided          Treatment included Tylenol and Aleve.  Action taken with mRNA-1273 in response to events was not applicable.
Information has been received from a health professional concerning a 17 year old female who on 06-NOV-2006 was vaccinated with the first dose of GARDASIL (lot #653735/0688F).  On 03-JAN-2007, the patient was vaccinated with the second dose of GARDASIL (lot #653735/0688F).  On 02-MAY-2007, the patient presented for the third dose of GARDASIL.  Prior to the vaccination, a pregnancy test was performed, which was positive.  The patient last menstrual period was in February 2007, with an expected delivery date of November 2007.  In follow up telephone call to the doctor's office the nurse reported that the patient terminated her pregnancy.  No further information was provided.  Upon internal review "abortion induced" was determined to be an other important medical event.  Additional information has been requested.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a male patient who didn't do well. the patient received a dose on an unspecified date. The patient didn't do well. The outcome of the event is unknown. No additional information was available at the time of this report.
No significant symptoms on the day of the vaccine, I had general body aches and fatigue for about 24 hours. I contracted COVID19, my symptoms started on September 21st but I tested positive on October 1st and that resolved pretty quickly. I only took a few ibuprofen for body aches and sore throat and I may have taken some DAYQUIL at some point for a bad cough. A few weeks later, October 25th, I went to go donate blood and my blood pressure was really high, 180s over 130s, and they told me to go calm down and come back. Came back and tested again later and it was still the same, so they recommended I see my PCP. My PCP monitored my blood pressure for 3 months and it remained high, which is something I've never had an issue with. She started me on low dose lisinopril which has helped a little but it's still marginally high, we are continuing to monitor it. The only other thing is that I still have fatigue since having COVID19.
dizziness; disorientation; Brief episodes of vertigo; occasionally walked by keeping hands on wall; Brief episode of nausea; unable to stand without falling down; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9265), via an unspecified route of administration in right arm on 02Feb2021 at 14:00 (at the age of 74 years old) as single for covid-19 immunisation. Medical history included minor hypertension, chronic obstructive pulmonary disease. Concomitant medications in two weeks included amlodipine; simvastatin; hctz; triamterene (TRIAMTENE); chondroitin sulfate sodium, glucosamine hydrochloride (OSTEO-BI-FLEX) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 03Feb2021, at 02:00 AM, 12 hours after shot patient experienced dizziness, disorientation; unable to stand without falling down; could move by crawling on hand and knees. No loss of consciousness. Brief episodes of vertigo (room spinning). Brief episode of nausea (24 hours after shot) less dizziness, occasionally walked by keeping hands on wall. Nausea gone. (10 days after shot) still some dizziness with head movement. No problem when sitting down or driving. Dizziness seems associated with change in position of head. Only minor improvement in dizziness since 3 days after shot. Generally able to walk slowly with great attention to movement. The patient did not received treatment due to the events. The outcome of brief episode of nausea was recovered on an unspecified date in 2021, while with other events was recovering.  Follow-up (10Jun2021): Follow-up attempts completed. No further information expected.
I received the flu vaccine on Thursday afternoon. I started having a dry cough Sat night. I still have it. I have not had ANY other symptoms except the cough. (No fever, throat issues, no runny nose, no sputum, no abdominal pain, diarrhea, vomiting, no malaise, etc.) I went to urgent care on 10/21 and received a ZPAK (to make sure it wasn't a case of bacterial bronchitis), TESSALON PERLES, I am now taking DELSYM 30mg cough suppressant dextromethorphan...still coughing.
A non-serious spontaneous report of "inadvertently gave two kids H1N1 LAIV that was expired" was received from a health professional concerning a seven-year-old female child Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 23-Feb-2010. On 02-Mar-2010, the patient received expired H1N1, Intranasal, for unknown indication. There was no adverse event associated with this medication error therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
This spontaneous report as received from a pharmacist refers to a 61 year old female patient with rheumatoid arthritis, high blood pressure and high cholesterol. On 23-MAY-2013, the patient was vaccinated with ZOSTAVAX (lot # H017448, Exp date 20-DEC-2013), 0.65 ml, subcutaneous in the arm. On an unspecified date after ZOSTAVAX was administered to a patient on 23-MAY-2013, the patient developed a dark mark and tenderness at the injection site. The dark mark was still present on the patient's arm and that area felt tender upon palpation. There was not treatment given for the adverse event. No lab diagnostics studies were performed. At the time of reporting, the outcome of the events was reported as recovering. It was reported that the patient had came back to see the pharmacist. Additional information has been requested.
Fever, Sore Throat, New olfactory and Taste Disorder's, Headache, and Cough
Pt 2nd does of Pfizer and started having pain in left knee a few hours after. Left knee pain/swelling x 8 days Started 2 hours after COVID vaccine Dx with  Synovial cyst of left popliteal space
Ache started at injection point and during the night ache spread to shoulder. By morning on 9/30/2016 aching was down left side of back around left shoulder and down left arm. Aching still exists today 10/4/2016.
AFTER 1ST IMMUN DEVELOPED FEVER AND PERSISTANT SCREAMING FOR 3 HRS.  HOSPITALIZED FOR ABSERVATION.  DOING FINE AT TIME OF REPORT
SORENESS/RASH AT INJECTION SITE; MUSCLE ACHES Narrative:  BOOSTER
Moderna COVID-19 vaccine EUA  Residual muscle ache at injection site  (right deltoid) now sill  19 days after injection. No treatment given- no Tylenol or other pain relievers taken during vaccination or after. Arm is dominant.
Sweeling in bicep...lymph swollen in armpit...redness...hot at injection site...
tingling on the tongue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administration date 18Feb2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LOSARTAN; METOPROLOL [METOPROLOL TARTRATE]; LIPITOR [ATORVASTATIN CALCIUM]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 24Jan2021, when the patient was 81 years old, for Covid-19 immunization, reaction(s): "Dry mouth", "tingling tongue", "For the past 3 days tingling was worse", "Dry tongue". The following information was reported: PARAESTHESIA ORAL (non-serious), outcome "not recovered", described as "tingling on the tongue". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The day of first vaccine experienced dry tongue, dry mouth from days later experienced tingling on the tongue, for the past 3 days the tingling was worse, she reported to Pfizer and her doctor. Dr advised a brain scan, results were negative. 18Feb2021 received second vaccination. The patient still had tingling on tongue on an unknown date. No other ill effects. Saw Neurologist, saw Ent- no known reason as yet. She was still experiencing the tingling on her tongue would be happy to hear from you and add to any finding as she find then.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
This spontaneous report as received from a physician refers to a 5 year old patient. On 08-NOV-2013 the patient was vaccinated with an adult dose of RECOMBIVAX HB (lot #, expiration date, dose, route, indication not reported) instead of a pediatric dose of RECOMBIVAX HB. No adverse effects reported. Additional information has been requested.
Mom reports 48 hours post vaccination, pt developed fever, muscle aches & general malaise. Sx lasted x 48 hours - T max 103 degrees F (missed 2 days of school). Then subsided. Had a nickel sized "knot" "in one of his arms".
I felt like I had the flu might have been sinus infection. I still exp cough a month later and voice is hoarse month later. I had a doctor appointment was advised just to take it easy take over the counter cough syrup.